EULON lower limb exoskeleton gait training system, Texo series lower limb exoskeleton robot (Texo-P1.5), approved by NMPA (formerly CFDA) medical device product registration certificate. This approval marks that EULON will further deepen the rehabilitation exoskeleton market expansion and basically achieve standardized development.

Rehabilitation Exoskeleton Technology Innovation

Deepening Human-Machine Integration Technology Field

In February 2022, the State Council issued the "14th Five-Year Plan for National Aging Development and Elderly Service System," emphasizing accelerating the integrated application of new technologies such as artificial intelligence, brain science, virtual reality, and wearable devices in health-promoting rehabilitation assistive devices, and developing rehabilitation assistive devices such as exoskeleton rehabilitation training.

In April 2022, the National Health Commission and other departments jointly issued "Opinions on Accelerating the Development of Rehabilitation Medical Work," which added 25 new rehabilitation projects, including somatic intelligent operation system training and upper limb intelligent feedback training.

It can be seen that for patients and elderly people with limited mobility undergoing rehabilitation treatment and assisted movement recovery, the benefits of exoskeleton robots far exceed traditional mobility, walking assistance, and rehabilitation equipment.

Given the current shortage of rehabilitation physicians in China and the difficulty in popularizing existing exoskeleton products, EULON Robotics has established a human big data dynamics model to explore optimal assistance mechanisms in different environments, and developed a full-cycle rehabilitation exoskeleton suitable for various lower limb dysfunction patients - Texo series lower limb exoskeleton robot.

The Texo series lower limb exoskeleton gait training system is designed for people with lower limb mobility impairments, helping wearers perform scientific, efficient, and accurate walking rehabilitation training, thereby stimulating nervous system remodeling and improving lower limb autonomous walking ability. Currently, the Texo series lower limb exoskeleton robot has been approved by the National Medical Products Administration (NMPA) as a Class II medical device registration, ensuring safety and effectiveness.

The Texo series lower limb exoskeleton robot has been deployed in cooperation with multiple hospitals nationwide. In 2023, EULON will continue to make efforts to deepen cooperation with existing medical and elderly care institutions. EULON Robotics has always hoped to help more patients with limb mobility impairments regain new lives by continuously optimizing its self-developed lower limb exoskeleton gait training system.